Aaron S Meyer

Aaron S Meyer is an Associate Professor of Bioengineering at the Henry Samueli School of Engineering and Applied Science, University of California Los Angeles (UCLA). He leads the Meyer Lab, which focuses on applying experimental and computational strategies to measure, model, and therapeutically manipulate cell-to-cell communication, with applications in immune and cancer therapies.

• Current Position: Associate Professor with tenure (promoted July 1, 2023)
• Institution: University of California Los Angeles
• School: Henry Samueli School of Engineering and Applied Science
• Department: Bioengineering
• Lab: Meyer Lab at UCLA
• Contact: ameyer@ucla.edu | (310) 794-4821

Dr. Meyer's research interests center on systems biology approaches to understand complex biological systems, particularly focusing on immune system communication and cancer. His work integrates computational modeling with experimental approaches to:

• Develop mathematical models of cell-to-cell communication
• Engineer cell-selective cytokines and antibodies
• Understand immune responses in transplantation and cancer
• Create tensor-based methods for integrating high-dimensional biological data
• Develop computational algorithms for pattern matching across biological datasets

Dr. Meyer's publications demonstrate a strong focus on applying tensor decomposition and other computational methods to analyze complex immune responses, particularly in the context of antibody Fc functions, cytokine signaling, and cancer immunotherapy. His recent work has increasingly focused on translational applications, with several studies examining clinical implications for cancer treatment and organ transplantation.

Scientific Awards and Honors

• Emerging Leader Award, Mark Foundation for Cancer Research (2023-2025)
• Northrop Grumman Excellence in Teaching Award, UCLA Engineering (2021)
• Ten to Watch, Amgen Scholars Foundation (2016)
• NIH Director's Early Independence Award, National Institutes of Health (2014-2019)

Dr. Meyer has successfully mentored numerous graduate students to completion of their PhDs, including Jackson Chin, Cyrillus Tan, Brian Orcutt-Jahns, Farnaz Mohammadi, and Marc Creixell. His laboratory has secured significant research funding, including multiple NIH grants as Principal Investigator. Current major projects include "Mapping the effector response space of antibody combinations" (NIH U01AI148119), "Precision lung cancer therapy design through multiplexed adapter measurement" (NIH U01CA215709), and "Adapter-Layer RTK Signaling: Basic Understanding & Targeted Drug Resistance" (NIH DP5OD019815). Recent additional grants focus on SARS-CoV-2 vaccination durability in kidney transplant recipients and studying Staphylococcus aureus and Candida albicans infections.

The Meyer Lab maintains active collaborations across UCLA and with other institutions, particularly in the areas of immunology, transplantation, and cancer research. The lab has established partnerships with industry, including an agreement with Merck to profile antibody effector responses.